French biotech company Afyren has just secured €21 million in a funding round led by Sofinnova Partners and Valquest Partners. The startup specialises in microbiology and bio-processing technology.
Combining the previous investments by AFY Partners and Sofimac Régions, Afyren has managed to bring its total funding amount to more than €60 million.